Recent Development of 1,2,4-triazole-containing Compounds as Anticancer Agents

Author(s): Xiaoyue Wen, Yongqin Zhou*, Junhao Zeng, Xinyue Liu

Journal Name: Current Topics in Medicinal Chemistry

Volume 20 , Issue 16 , 2020

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


1,2,4-Triazole derivatives possess promising in vitro and in vivo anticancer activity, and many anticancer agents such as fluconazole, tebuconazole, triadimefon, and ribavirin bear a 1,2,4-triazole moiety, revealing their potential in the development of novel anticancer agents. This review emphasizes the recent advances in 1,2,4-triazole-containing compounds with anticancer potential, and the structureactivity relationships as well as mechanisms of action are also discussed.

Keywords: 1, 2, 4-triazole, Anticancer, Structure-activity relationship, Fluconazole, Tebuconazole, Triadimefon, Ribavirin.

Latest global cancer data: Cancer burden rises to 18.1 million new cases and 9.6 million cancer deaths in 2018. Available From. (Accessed 2018).
American Association for Cancer Research. Cancer progress report, 2019.Available From. (Accessed 2019).
Mansoori, B.; Mohammadi, A.; Davudian, S.; Shirjang, S.; Baradaran, B. The different mechanisms of cancer drug resistance: A brief review. Adv. Pharm. Bull., 2017, 7(3), 339-348.
[] [PMID: 29071215]
Gottesman, M.M. Mechanisms of cancer drug resistance. Annu. Rev. Med., 2002, 53, 615-627.
[] [PMID: 11818492]
Gao, F.; Wang, T.; Xiao, J.; Huang, G. Antibacterial activity study of 1,2,4-triazole derivatives. Eur. J. Med. Chem., 2019, 173, 274-281.
[] [PMID: 31009913]
Küçükgüzel, Ş.G.; Çıkla-Süzgün, P. Recent advances bioactive 1,2,4-triazole-3-thiones. Eur. J. Med. Chem., 2015, 97, 830-870.
[] [PMID: 25563511]
Ayati, A.; Emami, S.; Foroumadi, A. The importance of triazole scaffold in the development of anticonvulsant agents. Eur. J. Med. Chem., 2016, 109, 380-392.
[] [PMID: 26826582]
Kaproń, B.; Łuszczki, J.J.; Płazińska, A.; Siwek, A.; Karcz, T.; Gryboś, A.; Nowak, G.; Makuch-Kocka, A.; Walczak, K.; Langner, E.; Szalast, K.; Marciniak, S.; Paczkowska, M.; Cielecka-Piontek, J.; Ciesla, L.M.; Plech, T. Development of the 1,2,4-triazole-based anticonvulsant drug candidates acting on the voltage-gated sodium channels. Insights from in-vivo, in-vitro, and in-silico studies. Eur. J. Pharm. Sci., 2019, 129, 42-57.
[] [PMID: 30594731]
Kaur, P.; Chawla, A. 1,2,4-Triazole: A review of pharmacological activities. Int. Res. J. Pharm., 2017, 8, 10-29.
Peyton, L.R.; Gallagher, S.; Hashemzadeh, M. Triazole antifungals: a review. Drugs Today (Barc), 2015, 51(12), 705-718.
[PMID: 26798851]
Suleymanoğlu, N.; Ustabaş, R.; Direkel, Ş.; Alpaslan, Y.B.; Ünver, Y. 1,2,4-Triazole derivative with Schiff base; thiol-thione tautomerism, DFT study and antileishmanial activity. J. Mol. Struct., 2017, 1150, 82-87.
Suleymanoğlu, N.; Ünver, Y.; Ustabaş, R.; Direkel, Ş.; Alpaslan, Y.B. Antileishmanial activity study and theoretical calculations for 4-amino-1,2,4-triazole derivatives. J. Mol. Struct., 2017, 1144, 80-86.
Seelam, N.; Shrivastava, S.P.; Prasanthi, S.; Gupta, S. Synthesis and in vitro study of some fused 1,2,4-triazole derivatives as antimycobacterial agents. J. Saudi Chem. Soc., 2016, 20, 411-418.
Keri, R.S.; Patil, S.A.; Budagumpi, S.; Nagaraja, B.M. Triazole: A promising antitubercular agent. Chem. Biol. Drug Des., 2015, 86(4), 410-423.
[] [PMID: 25643871]
Cascioferro, S.; Parrino, B.; Spanò, V.; Carbone, A.; Montalbano, A.; Barraja, P.; Diana, P.; Cirrincione, G. An overview on the recent developments of 1,2,4-triazine derivatives as anticancer compounds. Eur. J. Med. Chem., 2017, 142, 328-375.
[] [PMID: 28851503]
Kaur, P.; Chawla, A. Recent developments on 1,2,4-triazole nucleus in anticancer compounds: A review. Int. Res. J. Pharm., 2017, 8, 10-29.
Meunier, B. Hybrid molecules with a dual mode of action: dream or reality? Acc. Chem. Res., 2008, 41(1), 69-77.
[] [PMID: 17665872]
Shaveta, ; Mishra, S.; Singh, P. Hybrid molecules: The privileged scaffolds for various pharmaceuticals. Eur. J. Med. Chem., 2016, 124, 500-536.
[] [PMID: 27598238]
Yu, H.; Li, Y.; Ge, Y.; Song, Z.; Wang, C.; Huang, S.; Jin, Y.; Han, X.; Zhen, Y.; Liu, K.; Zhou, Y.; Ma, X. Novel 4-anilinoquinazoline derivatives featuring an 1-adamantyl moiety as potent EGFR inhibitors with enhanced activity against NSCLC cell lines. Eur. J. Med. Chem., 2016, 110, 195-203.
[] [PMID: 26829280]
Xia, Y.; Duan, Q.; Zhao, B.H.; Li, D.F.; Hou, R.B. Design, synthesis and structure-activity relationship studies of novel 4-(1-adamantyl) phenyl analogues as hif-1α inhibitors. Med. Chem., 2016, 12(4), 338-346.
[] [PMID: 26548744]
Bao, X.; Sun, Y.; Bao, C.; Zhang, J.; Zou, S.; Yang, J.; Wu, C.; Wang, L.; Chen, G. Design, synthesis and evaluation of N-hydroxypropenamides based on adamantane to overcome resistance in NSCLC. Bioorg. Chem., 2019, 86, 696-704.
[] [PMID: 30831531]
Cincinelli, R.; Dallavalle, S.; Nannei, R.; Carella, S.; De Zani, D.; Merlini, L.; Penco, S.; Garattini, E.; Giannini, G.; Pisano, C.; Vesci, L.; Carminati, P.; Zuco, V.; Zanchi, C.; Zunino, F. Synthesis and structure-activity relationships of a new series of retinoid-related biphenyl-4-ylacrylic acids endowed with antiproliferative and proapoptotic activity. J. Med. Chem., 2005, 48(15), 4931-4946.
[] [PMID: 16033272]
Gopalan, B.; Ponpandian, T.; Kachhadia, V.; Bharathimohan, K.; Vignesh, R.; Sivasudar, V.; Narayanan, S.; Mandar, B.; Praveen, R.; Saranya, N.; Rajagopal, S.; Rajagopal, S. Discovery of adamantane based highly potent HDAC inhibitors. Bioorg. Med. Chem. Lett., 2013, 23(9), 2532-2537.
[] [PMID: 23538115]
Cai, Y.; Yang, F.; Chai, X.Y.; Wang, T.; Wu, Q.Y.; Meng, Q.G. Synthesis and anti-breast cancer activity of azole derivatives. Acad. J. Sec. Mil. Med. Univ., 2016, 37, 349-354.
Milošev, M.Z.; Jakovljević, K.; Joksović, M.D.; Stanojković, T.; Matić, I.Z.; Perović, M.; Tešić, V.; Kanazir, S.; Mladenović, M.; Rodić, M.V.; Leovac, V.M.; Trifunović, S.; Marković, V. Mannich bases of 1,2,4-triazole-3-thione containing adamantane moiety: Synthesis, preliminary anticancer evaluation, and molecular modeling studies. Chem. Biol. Drug Des., 2017, 89(6), 943-952.
[] [PMID: 27933733]
Genc, Z.K.; Tekin, S.; Sandal, S.; Genc, M. Theoretical calculations, cytotoxic evaluation, and molecular docking studies of 4-(1-adamantyl)-5-[2-(3-hydroxynapthyl)]-2H-1,2,4-triazole-3(4H)-thione as a novel chemotherapeutic agent. Res. Chem. Intermed., 2015, 41, 6229-3244.
Zhang, S.; Xu, Z.; Gao, C.; Ren, Q.C.; Chang, L.; Lv, Z.S.; Feng, L.S. Triazole derivatives and their anti-tubercular activity. Eur. J. Med. Chem., 2017, 138, 501-513.
[] [PMID: 28692915]
Zhang, J.; Wang, S.; Ba, Y.; Xu, Z. Tetrazole hybrids with potential anticancer activity. Eur. J. Med. Chem., 2019, 178, 341-351.
[] [PMID: 31200236]
Kaur, R.; Dwivedi, A.R.; Kumar, B.; Kumar, V. Recent developments on 1,2,4-triazole nucleus in anticancer compounds: A review. Anticancer. Agents Med. Chem., 2016, 16(4), 465-489.
[] [PMID: 26286663]
Subba Rao, A.V.; Swapna, K.; Shaik, S.P.; Lakshma Nayak, V.; Srinivasa Reddy, T.; Sunkari, S.; Shaik, T.B.; Bagul, C.; Kamal, A. Synthesis and biological evaluation of cis-restricted triazole/tetrazole mimics of combretastatin-benzothiazole hybrids as tubulin polymerization inhibitors and apoptosis inducers. Bioorg. Med. Chem., 2017, 25(3), 977-999.
[] [PMID: 28034647]
Ye, J.; Xiao, M.W.; Xie, X.Q.; Qiu, S.Y.; Dai, M.C.; Li, W.; Hen, F.; Hu, A.X. Synthesis and cytotoxicity in vitro of N-aryl-4-(tert-butyl)-5-(1H-1,2,4-triazol-1-yl)thiazol-2-amine. J. Chin. Chem. Soc. (Taipei), 2015, 62, 627-631.
Ostapiuk, Y.V.; Frolov, D.A.; Vasylyschyn, R.Y.; Matiychuk, V.S. Synthesis and antitumor activities of new N-(5-benzylthiazol-2-yl)-2-(heteryl-5-ylsulfanyl)-acetamides. Biopolymers Cell, 2018, 34, 59-71.
Bansal, K.K.; Sharma, D.; Sharma, A.; Rajak, H.; Sharma, P.C. Novel thiazole clubbed triazole derivatives as antimicrobial, antimalarial, and cytotoxic agents. Indian J. Heterocycl. Chem., 2018, 28, 305-312.
Pogaku, V.; Eslavath, R.K.; Dayakar, G.; Singh, S.S.; Basavoju, S. Synthesis and biological evaluation of novel triazole substituted pyrazolyl-methylenehydrazinyl-5-arylidene thiazolidinone derivatives as antibacterial and cytotoxic agents. Res. Chem. Intermed., 2017, 43, 6079-6098.
Abdelazeem, A.H.; El-Saadi, M.T.; Said, E.G.; Youssif, B.G.M.; Omar, H.A.; El-Moghazy, S.M. Novel diphenylthiazole derivatives with multi-target mechanism: Synthesis, docking study, anticancer and anti-inflammatory activities. Bioorg. Chem., 2017, 75, 127-138.
[] [PMID: 28938224]
El-Sherief, H.A.M.; Youssif, B.G.M.; Abbas Bukhari, S.N.; Abdelazeem, A.H.; Abdel-Aziz, M.; Abdel-Rahman, H.M. Synthesis, anticancer activity and molecular modeling studies of 1,2,4-triazole derivatives as EGFR inhibitors. Eur. J. Med. Chem., 2018, 156, 774-789.
[] [PMID: 30055463]
Ribeiro, C.J.A.; Kankanala, J.; Shi, K.; Kurahashi, K.; Kiselev, E.; Ravji, A.; Pommier, Y.; Aihara, H.; Wang, Z. New fluorescence-based high-throughput screening assay for small molecule inhibitors of tyrosyl-DNA phosphodiesterase 2 (TDP2). Eur. J. Pharm. Sci., 2018, 118, 67-79.
[] [PMID: 29574079]
Chowrasia, D.; Karthikeyan, C.; Choure, L.; Sahabjada, M.; Arshad, M.; Trivedi, P. Synthesis, characterization and anti-cancer activity of some fluorinated 3,6-diaryl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles. Arab. J. Chem., 2017, 10, S2424-S2428.
Xu, Q.; Sun, M.; Bai, Z.; Wang, Y.; Wu, Y.; Tian, H.; Zuo, D.; Guan, Q.; Bao, K.; Wu, Y.; Zhang, W. Design, synthesis and bioevaluation of antitubulin agents carrying diaryl-5,5-fused-heterocycle scaffold. Eur. J. Med. Chem., 2017, 139, 242-249.
[] [PMID: 28802124]
Rostom, S.A.F.; Badr, M.H.; Abd El Razik, H.A.; Ashour, H.M.A. Structure-based development of novel triazoles and related thiazolotriazoles as anticancer agents and Cdc25A/B phosphatase inhibitors. Synthesis, in vitro biological evaluation, molecular docking and in silico ADME-T studies. Eur. J. Med. Chem., 2017, 139, 263-279.
[] [PMID: 28803043]
Zhang, B. Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids. Eur. J. Med. Chem., 2019, 168, 357-372.
[] [PMID: 30826511]
Zhang, J.; Wang, S.; Ba, Y.; Xu, Z. 1,2,4-Triazole-quinoline/quinolone hybrids as potential anti-bacterial agents. Eur. J. Med. Chem., 2019, 174, 1-8.
[] [PMID: 31015103]
Xu, Z.; Zhao, S.J.; Liu, Y. 1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships. Eur. J. Med. Chem., 2019, 183, 111700
[] [PMID: 31546197]
Wu, G.; Wang, H.; Zhou, W.; Zeng, B.; Mo, W.; Zhu, K.; Liu, R.; Zhou, J.; Chen, C.; Chen, H. Synthesis and structure-activity relationship studies of MI-2 analogues as MALT1 inhibitors. Bioorg. Med. Chem., 2018, 26(12), 3321-3344.
[] [PMID: 29751989]
Ren, Q.C.; Gao, C.; Xu, Z.; Feng, L.S.; Liu, M.L.; Wu, X.; Zhao, F. Bis-coumarin derivatives and their biological activities. Curr. Top. Med. Chem., 2018, 18(2), 101-113.
[] [PMID: 29473509]
Fröhlich, T.; Çapcı Karagöz, A.; Reiter, C.; Tsogoeva, S.B. Artemisinin-derived dimers: Potent antimalarial and anti-cancer agents. J. Med. Chem., 2016, 59(16), 7360-7388.
[] [PMID: 27010926]
Ali, K.A.; Elsayed, M.A.; Elhallouty, S.M.; Mahmoud, K.; Farag, A.M. Synthesis and antitumor screening of some new 2,6-bispyridine functionalized with pyrazole-based heterocycles. Acta Pol. Pharm.-. Drug Res. (Stuttg.), 2015, 72, 1193-1200.
Azab, I.H.E.; Elkanzi, N.A.A. Synthesis and in vitro anti-tumor activity of some new sebacoyl chloride based heterocycles. Curr. Org. Synth., 2017, 14, 309-320.
Utthra, P.P.; Raman, N. Probing the potency of triazole tethered Schiff base complexes and the effect of substituents on their biological attributes. Int. J. Biol. Macromol., 2018, 116, 194-207.
[] [PMID: 29733928]
Parlak, A.E.; Tekin, S.; Karatepe, A.; Koparir, P.; Telceken, H.; Ceribası, A.O.; Karatepe, M. In vitro and histological investigation of antitumor effect of some triazole compounds in colon cancer cell line. J. Cell. Biochem., 2019, 120, e11809
[] [PMID: 30770576]
Bae, S.H.; Park, J.H.; Choi, H.G.; Kim, H.; Kim, S.H. Imidazole antifungal drugs inhibit the cell proliferation and invasion of human breast cancer cells. Biomol. Ther. (Seoul), 2018, 26(5), 494-502.
[] [PMID: 30092625]
Wei, Z.Y.; Cui, B.R.; Cui, X.; Wu, Y.L.; Fu, Y.; Liu, L.P.; Piao, H.R. Design, synthesis, and negative inotropic evaluation of 4-phenyl-1H-1,2,4-triazol-5(4H)-one derivatives containing triazole or piperazine moieties. Chem. Biol. Drug Des., 2017, 89(1), 47-60.
[] [PMID: 27465664]
Pace, J.R.; DeBerardinis, A.M.; Sail, V.; Tacheva-Grigorova, S.K.; Chan, K.A.; Tran, R.; Raccuia, D.S.; Wechsler-Reya, R.J.; Hadden, M.K. Repurposing the clinically efficacious antifungal agent Itraconazole as an anticancer chemotherapeutic. J. Med. Chem., 2016, 59(8), 3635-3649.
[] [PMID: 27014922]
Liu, J.J.; Zhao, M.Y.; Zhang, X.; Zhao, X.; Zhu, H.L. Pyrazole derivatives as antitumor, anti-inflammatory and antibacterial agents. Mini Rev. Med. Chem., 2013, 13(13), 1957-1966.
[] [PMID: 23937232]
Chauhan, S.; Paliwal, S.; Chauhan, R. Anticancer activity of pyrazole via different biological mechanisms. Synth. Commun., 2014, 44, 1333-1374.
Gu, W.; Dai, Y.; Qiang, H.; Shi, W.; Liao, C.; Zhao, F.; Huang, W.; Qian, H. Discovery of novel 2-substituted-4-(2-fluorophenoxy) pyridine derivatives possessing pyrazolone and triazole moieties as dual c-Met/VEGFR-2 receptor tyrosine kinase inhibitors. Bioorg. Chem., 2017, 72, 116-122.
[] [PMID: 28411406]
Sun, S.; Zhang, Z.; Pokrovskaia, N.; Chowdhury, S.; Jia, Q.; Chang, E.; Khakh, K.; Kwan, R.; McLaren, D.G.; Radomski, C.C.; Ratkay, L.G.; Fu, J.; Dales, N.A.; Winther, M.D. Discovery of triazolone derivatives as novel, potent stearoyl-CoA desaturase-1 (SCD1) inhibitors. Bioorg. Med. Chem., 2015, 23(3), 455-465.
[] [PMID: 25555732]
Farghaly, T.A.; Gomha, S.M.; Mousa, E.K.; Elaasser, M. Hydrazonoyl chlorides in the synthesis of pyrazolo[5,1-c][1,2,4]triazole derivatives and their biological activities. J. Chem. Res., 2016, 40, 467-470.
Zejat, R.; Mahjoub, M.A.; Hekmatian, Z.; Javidi, M.A.; Babashah, S. Zeolite-catalyzed synthesis of pyrazolo[1,2-a][1,2,4]triazole-1,3-dione derivatives as anti-breast cancer agents. J. Iran. Chem. Soc., 2018, 15, 1133-1143.
Mojzych, M.; Tarasiuk, P.; Karczmarzyk, Z.; Juszczak, M.; Rzeski, W.; Fruzinski, A.; Wozny, A. Synthesis, Structure and Antiproliferative Activity of New pyrazolo[4,3- e]triazolo[4,5-b][1,2,4]triazine Derivatives. Med. Chem., 2018, 14(1), 53-59.
[] [PMID: 29065838]
Zhang, H.Z.; Zhao, Z.L.; Zhou, C.H. Recent advance in oxazole-based medicinal chemistry. Eur. J. Med. Chem., 2018, 144, 444-492.
[] [PMID: 29288945]
Kaur, R.; Palta, K.; Kumar, M.; Bhargava, M.; Dahiya, L. Therapeutic potential of oxazole scaffold: a patent review (2006-2017). Expert Opin. Ther. Pat., 2018, 28(11), 783-812.
[] [PMID: 30239247]
Abu-Bakr, S.M.; Roaiah, H.M.; Fawzy, N.M.; Omar, M.A.; Youns, M.M. Design, synthesis and antitumor activities of some novel benzoxazole carbohydrazide derivatives. Res. J. Pharm. Biol. Chem. Sci., 2017, 8, 68-78.
El-Nezhawy, A.O.H.; Eweas, A.F.; Radwan, M.A.A.; El-Naggar, T.B.A. Synthesis and molecular docking studies of novel 2-phenyl-4-substituted oxazole derivatives as potential anti-cancer agents. J. Heterocycl. Chem., 2016, 53, 271-279.
Gomha, S.M.; Badry, M.G.; Abdalla, M.M. Isoxazolopyrimidinethione and isoxazolopyridopyrimidinethione derivatives: Key intermediates for synthesis of novel fused triazoles as potent 5α-Reductase inhibitors and anti-prostate cancer. J. Heterocycl. Chem., 2016, 53, 558-565.
Nassar, I.F.; Att-Allah, S.R.; Hemdan, M.M. Utility of thiophene-2-carbonyl isothiocyanate as a precursor for the synthesis of 1,2,4-triazole, 1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives with evaluation of their antitumor and antimicrobial activities. Phosphorus Sulfur Silicon Relat. Elem., 2018, 193, 630-639.
Hudson, K.; Hancox, U.J.; Trigwell, C.; McEwen, R.; Polanska, U.M.; Nikolaou, M.; Morentin Gutierrez, P.; Avivar-Valderas, A.; Delpuech, O.; Dudley, P.; Hanson, L.; Ellston, R.; Jones, A.; Cumberbatch, M.; Cosulich, S.C.; Ward, L.; Cruzalegui, F.; Green, S. Intermittent high-dose scheduling of AZD8835, a novel selective inhibitor of PI3Kα and PI3Kδ, demonstrates treatment strategies for PIK3CA-dependent breast cancers. Mol. Cancer Ther., 2016, 15(5), 877-889.
[] [PMID: 26839307]
Avanzo, R.E.; Padrón, J.M.; D’Accorso, N.B.; Fascio, M.L. Synthesis and in vitro antiproliferative activities of (5-aryl-1,2,4-oxadiazole-3-yl) methyl d-ribofuranosides. Bioorg. Med. Chem. Lett., 2017, 27(16), 3674-3677.
[] [PMID: 28716494]
Li, Y.; Pasunooti, K.K.; Li, R.J.; Liu, W.; Head, S.A.; Shi, W.Q.; Liu, J.O. Novel tetrazole-containing analogues of Itraconazole as potent antiangiogenic agents with reduced cytochrome P450 3A4 inhibition. J. Med. Chem., 2018, 61(24), 11158-11168.
[] [PMID: 30481027]
Karaali, N.; Mentese, E. Synthesis and study of antitumor activity of some new 2-(4-methoxybenzyl)-1H-benzimidazole derivatives bearing triazole, oxadiazole and ethanol moiety. Rev. Roum. Chim., 2016, 61, 187-192.
Elhady, H.A.; El-Sayed, R.; Al-Nathali, H.S. Design, synthesis and evaluation of anticancer activity of novel 2-thioxoimidazolidin-4-one derivatives bearing pyrazole, triazole and benzoxazole moieties. Chem. Cent. J., 2018, 12(1), 51-63.
[] [PMID: 29740713]
Li, B.L.; Li, B.; Zhang, R.L.; Zhao, J.J.; Wang, X.F.; Liu, Y.M.; Shi, Y.P.; Liu, J.B.; Chen, B.Q. Synthesis and antiproliferative evaluation of novel 1,2,4-triazole derivatives incorporating benzisoselenazolone scaffold. Bioorg. Med. Chem. Lett., 2016, 26(4), 1279-1281.
[] [PMID: 26786698]
Yadav, V.R.; Prasad, S.; Sung, B.; Aggarwal, B.B. The role of chalcones in suppression of NF-κB-mediated inflammation and cancer. Int. Immunopharmacol., 2011, 11(3), 295-309.
[] [PMID: 21184860]
Sharma, V.; Kumar, V.; Kumar, P. Heterocyclic chalcone analogues as potential anticancer agents. Anticancer. Agents Med. Chem., 2013, 13(3), 422-432.
[PMID: 22721390]
Ahmed, F.F.; Abd El-Hafeez, A.A.; Abbas, S.H.; Abdelhamid, D.; Abdel-Aziz, M. New 1,2,4-triazole-Chalcone hybrids induce Caspase-3 dependent apoptosis in A549 human lung adenocarcinoma cells. Eur. J. Med. Chem., 2018, 151, 705-722.
[] [PMID: 29660690]
Li, W.; Yang, Z.H.; Hu, A.X.; Yan, X.W.; Ding, N.; Ye, J. Design, Synthesis, and Antitumor Activity of (E,Z)-1-(dihydrobenzofuran-5-yl)-3-phenyl-2-(1,2,4-triazol-1-yl)-2-propen-1-ones. Chem. Biol. Drug Des., 2015, 86(6), 1339-1350.
[] [PMID: 26041467]
Thakur, A.; Singla, R.; Jaitak, V. Coumarins as anticancer agents: a review on synthetic strategies, mechanism of action and SAR studies. Eur. J. Med. Chem., 2015, 101, 476-495.
[] [PMID: 26188907]
Dandriyal, J.; Singla, R.; Kumar, M.; Jaitak, V. Recent developments of C-4 substituted coumarin derivatives as anticancer agents. Eur. J. Med. Chem., 2016, 119, 141-168.
[] [PMID: 27155469]
Ballazhi, L.; Imeri, F.; Jashari, A.; Popovski, E.; Stojković, G.; Dimovski, A.J.; Mikhova, B.; Mladenovska, K. Original research paper. Hydrazinyldiene-chroman-2,4-diones in inducing growth arrest and apoptosis in breast cancer cells: Synergism with doxorubicin and correlation with physicochemical properties. Acta Pharm., 2017, 67(1), 35-52.
[] [PMID: 28231049]
Ballazhi, L.; Popovski, E.; Jashari, A.; Imeri, F.; Ibrahimi, I.; Mikhova, B.; Mladenovska, K. Potential antiproliferative effect of isoxazolo- and thiazolo coumarin derivatives on breast cancer mediated bone and lung metastases. Acta Pharm., 2015, 65(1), 53-63.
[] [PMID: 25781704]
Fan, M.C.; Han, G.Y.; Zhang, X.J.; Xi, H.F. Studies of in vitro anti-prostate cancer potential of newer 1,2,4-triazolo-1,3,4-thiadiazines with different heteroaromatics. Bangladesh J. Pharmacol., 2015, 10, 305-315.
Shen, Q.K.; Liu, C.F.; Zhang, H.J.; Tian, Y.S.; Quan, Z.S. Design and synthesis of new triazoles linked to xanthotoxin for potent and highly selective anti-gastric cancer agents. Bioorg. Med. Chem. Lett., 2017, 27(21), 4871-4875.
[] [PMID: 28947149]
Achar, G.; Shahini, C.R.; Patil, S.A.; Malecki, J.G.; Budagumpi, S. Coumarin-substituted 1,2,4-triazole-derived silver(I) and gold(I) complexes: Synthesis, characterization and anticancer studies. New J. Chem., 2019, 43, 1216-1299.
Liu, C.F.; Shen, Q.K.; Li, J.J.; Tian, Y.S.; Quan, Z. Synthesis and biological evaluation of novel 7-hydroxy-4-phenylchromen-2-one-linked to triazole moieties as potent cytotoxic agents. J. Enzyme Inhib. Med. Chem., 2017, 32(1), 1111-1119.
[] [PMID: 28791908]
Morsy, S.A.; Farahat, A.A.; Nasr, M.N.A.; Tantawy, A.S. Synthesis, molecular modeling and anticancer activity of new coumarin containing compounds. Saudi Pharm. J., 2017, 25(6), 873-883.
[] [PMID: 28951673]
Kahveci, B.; Yılmaz, F.; Menteşe, E.; Ülker, S. Design, synthesis, and biological evaluation of coumarin-triazole hybrid molecules as potential antitumor and pancreatic lipase agents. Arch. Pharm. (Weinheim), 2017, 350(8) e1600369
[] [PMID: 28543820]
Shaikh, S.K.J.; Sannaikai, M.S.; Kumbar, M.N.; Bayannavar, P.K.; Kamble, R.R.; Inamdar, S.R.; Joshi, S.D. Microwave-expedited green synthesis, photophysical, computational studies of coumarin-3-yl-thiazol-3-yl-1,2,4-triazolin-3-ones and their anticancer activity. ChemistrySelect, 2018, 3, 4448-4462.
Sable, P.M.; Potey, L.C. Synthesis and antiproliferative activity of imidazole and triazole derivatives of flavonoids. Pharm. Chem. J., 2018, 52, 438-443.
Al-Wahaibi, L.H.; Abu-Melha, H.M.; Ibrahim, D.A. Synthesis of novel 1,2,4-triazolyl coumarin derivatives as potential anticancer agents. J. Chem., 2018, 2018, e5201374
Ibrar, A.; Zaib, S.; Jabeen, F.; Iqbal, J.; Saeed, A. Unraveling the alkaline phosphatase inhibition, anticancer, and antileishmanial potential of coumarin-triazolothiadiazine hybrids: Design, synthesis, and molecular docking analysis. Arch. Pharm. (Weinheim), 2016, 349(7), 553-565.
[] [PMID: 27214743]
Gomha, S.M.; Abdel-aziz, H.M.; Badrey, M.G.; Abdulla, M.M. Efficient synthesis of some new 1,3,4-thiadiazoles and 1,2,4-triazoles linked to pyrazolylcoumarin ring system as potent 5α-reductase inhibitors. J. Heterocycl. Chem., 2019, 56, 1275-1282.
Patil, S.A.; Patil, R.; Miller, D.D. Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents. Future Med. Chem., 2012, 4(16), 2085-2115.
[] [PMID: 23157240]
Hou, Y.; Shang, C.; Wang, H.; Yun, J. Isatin–azole hybrids and their anticancer activities. Arch. der Pharm., 2019. [ePub Ahead of Print]
[] [PMID: 31691360]
Boraei, A.T.A.; Gomaa, M.S.; El Ashry, E.S.; Duerkop, A. Design, selective alkylation and X-ray crystal structure determination of dihydro-indolyl-1,2,4-triazole-3-thione and its 3-benzylsulfanyl analogue as potent anticancer agents. Eur. J. Med. Chem., 2017, 125, 360-371.
[] [PMID: 27688190]
Kang, H.; Xiao, X.; Huang, C.; Yuan, Y.; Tang, D.; Dai, X.; Zeng, X. Potent aromatase inhibitors and molecular mechanism of inhibitory action. Eur. J. Med. Chem., 2018, 143, 426-437.
[] [PMID: 29202405]
Das, A.; Narayanam, M.K.; Paul, S.; Mukhnerjee, P.; Ghosh, S.; Dastidar, D.G.; Chakrabarty, S.; Ganguli, A.; Basu, B.; Pal, M.; Chatterji, U.; Banerjee, S.K.; Karmakar, P.; Kumar, D.; Chakrabarti, G. A novel triazole, NMK-T-057, induces autophagic cell death in breast cancer cells by inhibiting γ-secretase-mediated activation of Notch signaling. J. Biol. Chem., 2019, 294(17), 6733-6750.
[] [PMID: 30824542]
Çıkla-Süzgün, P.; Kaushik-Basu, N.; Basu, A.; Arora, P.; Talele, T.T.; Durmaz, I.; Çetin-Atalay, R.; Küçükgüzel, Ş.G. Anti-cancer and anti-hepatitis C virus NS5B polymerase activity of etodolac 1,2,4-triazoles. J. Enzyme Inhib. Med. Chem., 2015, 30(5), 778-785.
[] [PMID: 25676325]
Çoruh, I.; Çevik, Ö.; Yelekçi, K.; Djikic, T.; Küçükgüzel, Ş.G. Synthesis, anticancer activity, and molecular modeling of etodolac-thioether derivatives as potent methionine aminopeptidase (type II) inhibitors. Arch. Pharm. (Weinheim), 2018, 351(3-4) e1700195
[] [PMID: 29575045]
Prachayasittikul, S.; Pingaew, R.; Worachartcheewan, A.; Sinthupoom, N.; Prachayasittikul, V.; Ruchirawat, S.; Prachayasittikul, V. Roles of pyridine and pyrimidine derivatives as privileged scaffolds in anticancer agents. Mini Rev. Med. Chem., 2017, 17(10), 869-901.
[] [PMID: 27670581]
Goel, R.; Luxami, V.; Paul, K. Imidazo[1,2-a]pyridines: Promising drug candidate for antitumor therapy. Curr. Top. Med. Chem., 2016, 16(30), 3590-3616.
[] [PMID: 27086790]
Akhtar, J.; Khan, A.A.; Ali, Z.; Haider, R.; Shahar Yar, M. Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities. Eur. J. Med. Chem., 2017, 125, 143-189.
[] [PMID: 27662031]
El-Sherief, H.A.M.; Youssif, B.G.M.; Bukhari, S.N.A.; Abdel-Aziz, M.; Abdel-Rahman, H.M. Novel 1,2,4-triazole derivatives as potential anticancer agents: Design, synthesis, molecular docking and mechanistic studies. Bioorg. Chem., 2018, 76, 314-325.
[] [PMID: 29227915]
Romagnoli, R.; Prencipe, F.; Oliva, P.; Baraldi, S.; Baraldi, P.G.; Brancale, A.; Ferla, S.; Hamel, E.; Bortolozzi, R.; Viola, G. 3-Aryl/Heteroaryl-5-amino-1-(3′,4′,5′-trimethoxybenzoyl)-1,2,4-triazoles as antimicrotubule agents. Design, synthesis, antiproliferative activity and inhibition of tubulin polymerization. Bioorg. Chem., 2018, 80, 361-374.
[] [PMID: 29986184]
Amr, A.E.G.E.; Abdalla, M.M. Anticancer activities of some synthesized 2,4,6-trisubstituted pyridine candidates. Biomed. Res., 2016, 27, 731-736.
El-Deen, E.M.M.; Mohamed, N.A. ZEl-Serwy, W. S.; Abdelghany, T. M.; Nossier, E. S. Synthesis, molecular docking and cytotoxicity evaluation of novel 1,2-disubstituted benzimidazole derivatives against liver and breast cancer cell lines. Res. J. Pharmaceut., 2016, 7, 1599-1614.
Hussein, E.M.; Al-Shareef, H.F.; Aboellil, A.H.; Elhady, H.A. Synthesis of some novel 6′-(4-chlorophenyl)-3,4′-bipyridine-3′-carbonitriles: Assessment of their antimicrobial and cytotoxic activity. Z. Naturforsch., 2015, 70, 783-795.
Megally Abdo, N.Y.; Kamel, M.M. Synthesis and anticancer evaluation of 1,3,4-oxadiazoles, 1,3,4-thiadiazoles, 1,2,4-triazoles and Mannich bases. Chem. Pharm. Bull. (Tokyo), 2015, 63(5), 369-376.
[] [PMID: 25948330]
Feng, L.S.; Xu, Z.; Chang, L.; Li, C.; Yan, X.F.; Gao, C.; Ding, C.; Zhao, F.; Shi, F.; Wu, X. Hybrid molecules with potential in vitro antiplasmodial and in vivo antimalarial activity against drug-resistant Plasmodium falciparum. Med. Res. Rev., 2019. [Epub ahead of print]
[] [PMID: 31692025]
Hu, Y.Q.; Zhang, S.; Xu, Z.; Lv, Z.S.; Liu, M.L.; Feng, L.S. 4-Quinolone hybrids and their antibacterial activities. Eur. J. Med. Chem., 2017, 141, 335-345.
[] [PMID: 29031077]
Gao, F.; Zhang, X.; Wang, T.; Xiao, J. Quinolone hybrids and their anti-cancer activities: An overview. Eur. J. Med. Chem., 2019, 165, 59-79.
[] [PMID: 30660827]
Musiol, R. An overview of quinoline as a privileged scaffold in cancer drug discovery. Expert Opin. Drug Discov., 2017, 12(6), 583-597.
[] [PMID: 28399679]
Anantacharya, R.; Satyanarayan, N.D.; Sukhlal Kalal, B.; Pai, V.R. Cytotoxic, DNA cleavage and pharmacokinetic parameter study of substituted novel furan C-2 quinoline coupled 1,2,4-triazole and its analogs. Open Med. Chem. J., 2018, 12, 60-72.
[] [PMID: 30008962]
Santoshkumar, S.; Manjulatha, K.; Satyanarayan, N.D.; Anantacharya, R.; Harishkumar, S.; Harishkumar, H.N.; Yallappa, S.; Dhananjaya, B.L. Antiproliferative, ADME and potential in silico G6PDH inhibitory activity of novel 2-(1-benzofuran-2-yl)-4-(5-phenyl-4H-1,2,4-triazol-3-yl)quinoline derivatives. Int. J. Pharm. Pharm. Sci., 2016, 8, 313-319.
Korcz, M.; Sączewski, F.; Bednarski, P.J.; Kornicka, A. Synthesis, structure, chemical stability, and in vitro cytotoxic properties of novel quinoline-3-carbaldehyde hydrazones bearing a 1,2,4-triazole or benzotriazole moiety. Molecules, 2018, 23(6) e1497
[] [PMID: 29925826]
Hamdy, R.; Elseginy, S.A.; Ziedan, N.I.; Jones, A.T.; Westwell, A.D. New quinoline-based heterocycles as anticancer agents targeting Bcl-2. Molecules, 2019, 24(7) e1274
[] [PMID: 30986908]
Liu, J.; Nie, M.; Wang, Y.; Hu, J.; Zhang, F.; Gao, Y.; Liu, Y.; Gong, P. Design, synthesis and structure-activity relationships of novel 4-phenoxyquinoline derivatives containing 1,2,4-triazolone moiety as c-Met kinase inhibitors. Eur. J. Med. Chem., 2016, 123, 431-446.
[] [PMID: 27490023]
Yuan, H.; Liu, Q.; Zhang, L.; Hu, S.; Chen, T.; Li, H.; Chen, Y.; Xu, Y.; Lu, T. Discovery, optimization and biological evaluation for novel c-Met kinase inhibitors. Eur. J. Med. Chem., 2018, 143, 491-502.
[] [PMID: 29202410]
Zhang, L.; Zhao, J.; Zhang, B.; Lu, T.; Chen, Y. Discovery of [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as novel, potent and selective c-Met kinase inhibitors: Synthesis, SAR study, and biological activity. Eur. J. Med. Chem., 2018, 150, 809-816.
[] [PMID: 29602036]
Zhang, H.; Wang, K.; Zhang, W.; Liu, R. Selenium dioxide-mediated synthesis of fused 1,2,4-triazoles as cytotoxic agents. Synth. Commun., 2015, 24, 2849-2856.
Reddy, B.N.; Reddy, P.V.G.; Reddy, P.S.; Reddy, S.M.; Reddy, S.R.S.; Pathak, M. Synthesis of new 4,5-dihydro-1-methyl-[1,2,4]triazolo[4,3-a]quinolin-7-amine-derived ureas and their anticancer activity. Synth. Commun., 2015, 45, 831-837.
Hou, F.; Tang, N.F.; Fan, Y.Y.; Liu, S.M.; Zhang, Y. Benzaldehyde levofloxacin Schiff base induces apoptosis of human hepatocarcinoma cells. Chin. Pharmacol. Bull., 2015, 31, 821-826.
Ni, L.L.; Yan, Q.; Wu, S.M.; Xie, Y.S.; Gao, L.Z.; Liu, Y.J.; Huang, W.L.; Hu, G.Q. [Synthesis and antitumor activity of fluoroquinolon-3-yl-s-triazole sulfide ketones and their derivatives from ciprofloxacin]. Yao Xue Xue Bao, 2015, 50(10), 1258-1262.
[PMID: 26837171]
Yan, Q.; Wu, S.; Ni, L.L.; Xie, Y.; Gao, L.; Huang, W.; Liu, Y.; Hu, G. Synthesis and antitumor activity of C-3 thiazolo[3,2-b][1,2,4]triazole-substituted pefloxacin derivatives. J. Chin. Pharm. Univ., 2015, 46, 548-551.
Gupta, A.; Kumar, B.S.; Negi, A.S. Current status on development of steroids as anticancer agents. J. Steroid Biochem. Mol. Biol., 2013, 137, 242-270.
[] [PMID: 23727548]
Njar, V.C.; Brodie, A.M. Discovery and development of Galeterone (TOK-001 or VN/124-1) for the treatment of all stages of prostate cancer. J. Med. Chem., 2015, 58(5), 2077-2087.
[] [PMID: 25591066]
Minorics, R.; Zupko, I. Steroidal anticancer agents: An overview of estradiol-related compounds. Anticancer. Agents Med. Chem., 2018, 18(5), 652-666.
[] [PMID: 29141561]
Silva-Ortiz, A.V.; Bratoeff, E.; Ramírez-Apan, M.T.; García-Becerra, R.; Ordaz-Rosado, D.; Noyola-Martínez, N.; Castillo-Bocanegra, R.; Barrera, D. Synthesis and biological activity of two pregnane derivatives with a triazole or imidazole ring at C-21. J. Steroid Biochem. Mol. Biol., 2016, 159, 8-18.
[] [PMID: 26924581]
Silva-Ortiz, A.V.; Bratoeff, E.; Ramírez-Apan, T.; Heuze, Y.; Sánchez, A.; Soriano, J.; Cabeza, M. Synthesis and activity of novel 16-dehydropregnenolone acetate derivatives as inhibitors of type 1 5α-reductase and on cancer cell line SK-LU-1. Bioorg. Med. Chem., 2015, 23(24), 7535-7542.
[] [PMID: 26631442]
Huang, L.H.; Zheng, Y.F.; Lu, Y.Z.; Song, C.J.; Wang, Y.G.; Yu, B.; Liu, H.M. Synthesis and biological evaluation of novel steroidal[17,16-d][1,2,4]triazolo[1,5-a]pyrimidines. Steroids, 2012, 77(6), 710-715.
[] [PMID: 22445685]
Arenas-González, A.; Mendez-Delgado, L.A.; Merino-Montiel, P.; Padrón, J.M.; Montiel-Smith, S.; Vega-Báez, J.L.; Meza-Reyes, S. Synthesis of monomeric and dimeric steroids containing [1,2,4]triazolo[1,5-a]pyrimidines. Steroids, 2016, 116, 13-19.
[] [PMID: 27692994]
Amin, L.H.T.; Shawer, T.Z.; El-Naggar, A.M.; El-Sehrawi, H.M.A. Design, synthesis, anticancer evaluation and docking studies of new pyrimidine derivatives as potent thymidylate synthase inhibitors. Bioorg. Chem., 2019, 91, 103159
[] [PMID: 31382056]
Ghith, A.; Youssef, K.M.; Ismail, N.S.M.; Abouzid, K.A.M. Design, synthesis and molecular modeling study of certain VEGFR-2 inhibitors based on thienopyrimidne scaffold as cancer targeting agents. Bioorg. Chem., 2019, 83, 111-128.
[] [PMID: 30343204]
Gilandoust, M.; Harsha, K.B.; Mohan, C.D.; Raquib, A.R.; Rangappa, S.; Pandey, V.; Lobie, P.E.; Basappa, ; Rangappa, K.S. Synthesis, characterization and cytotoxicity studies of 1,2,3-triazoles and 1,2,4-triazolo [1,5-a] pyrimidines in human breast cancer cells. Bioorg. Med. Chem. Lett., 2018, 28(13), 2314-2319.
[] [PMID: 29789259]
Sáez-Calvo, G.; Sharma, A.; Balaguer, F.A.; Barasoain, I.; Rodríguez-Salarichs, J.; Olieric, N.; Muñoz-Hernández, H.; Berbís, M.A.; Wendeborn, S.; Peñalva, M.A.; Matesanz, R.; Canales, Á.; Prota, A.E.; Jímenez-Barbero, J.; Andreu, J.M.; Lamberth, C.; Steinmetz, M.O.; Díaz, J.F. Triazolopyrimidines are microtubule-stabilizing agents that bind the vinca inhibitor site of tubulin. Cell Chem. Biol., 2017, 24(6), 737-750.e6.
[] [PMID: 28579361]
Bilyi, A.K.; Antypenko, L.M.; Ivchuk, V.V.; Kamyshnyi, O.M.; Polishchuk, N.M.; Kovalenko, S.I. 2-Heteroaryl-[1,2,4]triazolo[1,5-c]quinazoline-5(6H)-thiones and their S-substituted derivatives: Synthesis, spectroscopic data, and biological activity. ChemPlusChem, 2018, 80, 980-990.
Anumala, U.R.; Waaler, J.; Nkizinkiko, Y.; Ignatev, A.; Lazarow, K.; Lindemann, P.; Olsen, P.A.; Murthy, S.; Obaji, E.; Majouga, A.G.; Leonov, S.; von Kries, J.P.; Lehtiö, L.; Krauss, S.; Nazaré, M. Discovery of a novel series of tankyrase inhibitors by a hybridization approach. J. Med. Chem., 2017, 60(24), 10013-10025.
[] [PMID: 29155568]
Yan, L.; Liang, J.; Yao, C.; Wu, P.; Zeng, X.; Cheng, K.; Yin, H. Pyrimidine triazole thioether derivatives as Toll-like receptor 5 (TLR5)/flagellin complex inhibitors. ChemMedChem, 2016, 11(8), 822-826.
[] [PMID: 26634412]
Hou, Y.; Zhu, L.; Li, Z.; Shen, Q.; Xu, Q.; Li, W.; Liu, Y.; Gong, P. Design, synthesis and biological evaluation of novel 7-amino-[1,2,4]triazolo[4,3-f]pteridinone, and 7-aminotetrazolo[1,5-f]pteridinone derivative as potent antitumor agents. Eur. J. Med. Chem., 2019, 163, 690-709.
[] [PMID: 30572179]
Mishra, C.B.; Mongre, R.K.; Kumari, S.; Jeong, D.K.; Tiwari, M. Novel triazole-piperazine hybrid molecules induce apoptosis via activation of the mitochondrial pathway and exhibit antitumor efficacy in Osteosarcoma Xenograft nude mice model. ACS Chem. Biol., 2017, 12(3), 753-768.
[] [PMID: 28084722]
Murty, M.S.R.; Katiki, M.R.; Nanubolu, J.B.; Garimella, S.; Polepalli, S.; Jain, N.; Buddana, S.K.; Prakasham, R.S. Synthesis and biological evaluation of novel tamoxifen-1,2,4-triazole conjugates. Mol. Divers., 2016, 20(3), 687-703.
[] [PMID: 27278444]
Wang, X.F.; Zhang, S.; Li, B.L.; Zhao, J.J.; Liu, Y.M.; Zhang, R.L.; Li, B.; Chen, B.Q. Synthesis and biological evaluation of disulfides bearing 1,2,4-triazole moiety as antiproliferative agents. Med. Chem. Res., 2017, 26, 3367-3374.
Qin, M.; Yan, S.; Wang, L.; Zhang, H.; Zhao, Y.; Wu, S.; Wu, D.; Gong, P. Discovery of novel diaryl urea derivatives bearing a triazole moiety as potential antitumor agents. Eur. J. Med. Chem., 2016, 115, 1-13.
[] [PMID: 26991938]
Tokala, R.; Bale, S.; Janrao, I.P.; Vennela, A.; Kumar, N.P.; Senwar, K.R.; Godugu, C.; Shankaraiah, N. Synthesis of 1,2,4-triazole-linked urea/thiourea conjugates as cytotoxic and apoptosis inducing agents. Bioorg. Med. Chem. Lett., 2018, 28(10), 1919-1924.
[] [PMID: 29657100]
Xu, F.; Yang, Z.Z.; Jiang, J.R.; Pan, W.G.; Yang, X.L.; Wu, J.Y.; Zhu, Y.; Wang, J.; Shou, Q.Y.; Wu, H.G. Synthesis, antitumor evaluation and molecular docking studies of [1,2,4]triazolo[4,3-b][1,2,4,5]tetrazine derivatives. Bioorg. Med. Chem. Lett., 2016, 26(13), 3042-3047.
[] [PMID: 27184766]

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Published on: 21 July, 2020
Page: [1441 - 1460]
Pages: 20
DOI: 10.2174/1568026620666200128143230
Price: $65

Article Metrics

PDF: 28